fulvestrant medac 250 mg injektioneste, liuos, esitäytetty ruisku
medac gesellschaft fÜr klinische spezialprÄparate mbh - fulvestrant - injektioneste, liuos, esitäytetty ruisku - 250 mg - fulvestrantti
fulvestrant reddy 250 mg injektioneste, liuos, esitäytetty ruisku
reddy holding gmbh - fulvestrant - injektioneste, liuos, esitäytetty ruisku - 250 mg - fulvestrantti
faslodex
astrazeneca ab - fulvestrantti - rintojen kasvaimet - hormonaalisen hoidon, anti-estrogeenit - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. pre - tai huonomaineiset naiset, yhdistelmä-hoidon palbociclib olisi yhdistettävä luteinisoivan hormonin vapauttava hormoni (lhrh) - agonisteilla.
apurin sandoz 100 mg tabletti
sandoz a/s - allopurinol - tabletti - 100 mg - allopurinoli
apurin sandoz 300 mg tabletti
sandoz a/s - allopurinol - tabletti - 300 mg - allopurinoli
allopurinol sandoz 100 mg tabletti
sandoz a/s sandoz a/s - allopurinolum - tabletti - 100 mg - allopurinoli
allopurinol sandoz 300 mg tabletti
sandoz a/s sandoz a/s - allopurinolum - tabletti - 300 mg - allopurinoli
allopurinol mylan 100 mg tabletti
mylan ab - allopurinolum - tabletti - 100 mg - allopurinoli
allopurinol mylan 300 mg tabletti
mylan ab - allopurinolum - tabletti - 300 mg - allopurinoli
allopurinol accord 100 mg tabletti
accord healthcare b.v. accord healthcare b.v. - allopurinolum - tabletti - 100 mg - allopurinoli